Norway
· Delayed Price · Currency is NOK EXACT Therapeutics AS Statistics
Total Valuation
EXACT Therapeutics AS has a market cap or net worth of NOK 114.85 million. The enterprise value is 99.97 million.
| Market Cap | 114.85M |
| Enterprise Value | 99.97M |
Important Dates
The last earnings date was Friday, January 3, 2025.
| Earnings Date | Jan 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EXACT Therapeutics AS has 32.08 million shares outstanding. The number of shares has increased by 10.41% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 32.08M |
| Shares Change (YoY) | +10.41% |
| Shares Change (QoQ) | -6.10% |
| Owned by Insiders (%) | 23.35% |
| Owned by Institutions (%) | 3.88% |
| Float | 15.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.59 |
| P/TBV Ratio | 6.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.82 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.08 |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.02 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -175.64% and return on invested capital (ROIC) is -107.69%.
| Return on Equity (ROE) | -175.64% |
| Return on Assets (ROA) | -82.91% |
| Return on Capital (ROIC) | -107.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.57M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.67% in the last 52 weeks. The beta is 0.21, so EXACT Therapeutics AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -71.67% |
| 50-Day Moving Average | 4.45 |
| 200-Day Moving Average | 6.06 |
| Relative Strength Index (RSI) | 45.33 |
| Average Volume (20 Days) | 40,928 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -55.83M |
| Pretax Income | -54.89M |
| Net Income | -54.84M |
| EBITDA | -54.07M |
| EBIT | -55.83M |
| Earnings Per Share (EPS) | -1.66 |
Balance Sheet
The company has 15.80 million in cash and 922,318 in debt, giving a net cash position of 14.88 million or 0.46 per share.
| Cash & Cash Equivalents | 15.80M |
| Total Debt | 922,318 |
| Net Cash | 14.88M |
| Net Cash Per Share | 0.46 |
| Equity (Book Value) | 17.44M |
| Book Value Per Share | 0.54 |
| Working Capital | 13.51M |
Cash Flow
In the last 12 months, operating cash flow was -45.11 million and capital expenditures -3.06 million, giving a free cash flow of -48.17 million.
| Operating Cash Flow | -45.11M |
| Capital Expenditures | -3.06M |
| Free Cash Flow | -48.17M |
| FCF Per Share | -1.50 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EXACT Therapeutics AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.41% |
| Shareholder Yield | -10.41% |
| Earnings Yield | -46.25% |
| FCF Yield | -41.95% |
Stock Splits
The last stock split was on July 27, 2020. It was a forward split with a ratio of 250.
| Last Split Date | Jul 27, 2020 |
| Split Type | Forward |
| Split Ratio | 250 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |